Lifecore Biomedical, Inc.LFCRNASDAQ
Loading
Book Value/Share Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+538.3%
Year-over-Year Change
Year-over-year book value per share growth
3Y CAGR
+538.3%/yr
Quarterly compound
Percentile
P100
Near historical high
vs 3Y Ago
260.1x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 2625.71% |
| Q2 2025 | -40.07% |
| Q1 2025 | -86.61% |
| Q4 2024 | 452.29% |
| Q3 2024 | -134.47% |
| Q2 2024 | -36.18% |
| Q1 2024 | -58.27% |
| Q4 2023 | 59.18% |
| Q3 2023 | 726.08% |
| Q2 2023 | -112.36% |
| Q1 2023 | -53.89% |
| Q4 2022 | -25.28% |
| Q3 2022 | 10.10% |
| Q2 2022 | -40.39% |
| Q1 2022 | -5.82% |
| Q4 2021 | -19.74% |
| Q3 2021 | -4.48% |
| Q2 2021 | -1.01% |
| Q1 2021 | -5.27% |
| Q4 2020 | -3.50% |
| Q3 2020 | -3.63% |
| Q2 2020 | -6.63% |
| Q1 2020 | -4.45% |
| Q4 2019 | -2.27% |
| Q3 2019 | -2.04% |
| Q2 2019 | -0.60% |
| Q1 2019 | 2.25% |
| Q4 2018 | 0.02% |
| Q3 2018 | 0.15% |
| Q2 2018 | 0.43% |
| Q1 2018 | 7.41% |
| Q4 2017 | 0.57% |
| Q3 2017 | 1.29% |
| Q2 2017 | 1.00% |
| Q1 2017 | 1.99% |
| Q4 2016 | 1.05% |
| Q3 2016 | 1.90% |
| Q2 2016 | 2.42% |
| Q1 2016 | -8.92% |
| Q4 2015 | 1.12% |